Grants paid by Uncle Kory Foundation
EIN 46-4485313 · El Segundo, DE · Form 990-PF, Part XV · NTEE T99
Uncle Kory Foundation of El Segundo, DE (EIN 46-4485313) reported 42 grants paid totaling $1,746,190 to 19 recipients in tax years 2020–2024, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,746,190
42 grants
Recipients
19
distinct organizations
Tax years
2020–2024
4 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 7 | $390,000 | — |
| 2022 | 16 | $800,000 | — |
| 2023 | 8 | $121,190 | — |
| 2024 | 11 | $435,000 | — |
Top recipients
The 19 recipients receiving the most from Uncle Kory Foundation, by grants paid, out of 19 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| The UCLA Foundation 95-2250801 | B | Los Angeles, CA | 9 | $527,690 | 2024 |
| The University of Texas Md Anderson Cancer Center | U | Houston, TX | 6 | $300,000 | 2024 |
| Duke University 22-3114978 | B | Durham, NC | 4 | $153,500 | 2024 |
| Cornell University - Weill Cornell Medicine | U | Ithaca, NY | 2 | $100,000 | 2024 |
| City of Hope | U | Duarte, CA | 2 | $100,000 | 2024 |
| The Regents of Ucsf | U | San Francisco, CA | 1 | $50,000 | 2022 |
| Mayo Clinic | U | Rochester, MN | 1 | $50,000 | 2022 |
| Johns Hopkins University | U | Baltimore, MD | 1 | $50,000 | 2022 |
| Regents University of California 95-6006143 | C | Santa Cruz, CA | 1 | $50,000 | 2024 |
| Beckman Research Institute of the City of Hope | U | Duarte, CA | 1 | $50,000 | 2020 |
| University of Southern California 95-1642394 | C | Los Angeles, CA | 1 | $50,000 | 2023 |
| Society for Neuroscience 33-0756869 | C | Los Angeles, CA | 1 | $50,000 | 2022 |
| American Brain Tumor Association 23-7286648 | B | Chicago, IL | 1 | $50,000 | 2022 |
| University of Southern California | U | Los Angeles, CA | 1 | $50,000 | 2024 |
| Childrens Hospital Los Angeles | U | Los Angeles, CA | 1 | $50,000 | 2024 |
| Saint Johns Hospital & Health Center Foundation | U | Santa Monica, CA | 1 | $38,000 | 2020 |
| Central Brain Tumor Registry of the United States | U | Hinsdale, IL | 4 | $17,000 | 2024 |
| Brain Tumor Epidemiology Consortium | U | Hinsdale, IL | 3 | $9,000 | 2024 |
| Ourbrainbank Inc | U | Rocklin, CA | 1 | $1,000 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 42 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Regents University of California Santa Cruz, CA | C | $50,000 | paid | CHARACTERIZING PTPRZ1 MECHANISM IN CANCER AS A THERAPEUTIC TARGET, 2ND YEAR FUNDING | 202512539349100111 |
| 2024 | University of Southern California Los Angeles, CA | U | $50,000 | paid | THE ROLE OF GABA TRANSAMINASE IN MEDULLOBLASTOMA LOCAL RECURRENCE AND ITS POTENTIAL AS A THERAPEUTIC TARGET IN MEDULLOBLASTOMA METASTASIS 2ND YEAR FUNDING | 202512539349100111 |
| 2024 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | TO SUPPORT PROJECT "IDENTIFICATION OF NON-CANONICAL ANTIGENS OF DEVELOPMENT OF NOVEL IMMUNOTHERAPIES IN GLIOBLASTOMA. | 202512539349100111 |
| 2024 | Childrens Hospital Los Angeles Los Angeles, CA | U | $50,000 | paid | CEREBROSPINAL FLUID LIQUID BIOPSY ON PEDIATRIC EMBRYONAL CENTRAL NERVOUS SYSTEM TUMORS. | 202512539349100111 |
| 2024 | Cornell University - Weill Cornell Medicine Ithaca, NY | U | $50,000 | paid | TO FUND PROJECT "REGULATION OF MYELOID CELLS BY FATTY ACID METABOLISM IN IRRADIATED GLIOBLASTOMA." | 202512539349100111 |
| 2024 | Duke University Durham, NC | B | $50,000 | paid | THE CARE-BEAR PROPOSAL. | 202512539349100111 |
| 2024 | City of Hope Duarte, CA | U | $50,000 | paid | FUNDING PROJECT ADVANCING IL13RA2-CAR T CELL THERAPY AGAINST GLIOBLASTOMA BY ENHANCING IFNSIGNALING | 202512539349100111 |
| 2024 | The UCLA Foundation Los Angeles, CA | B | $37,500 | paid | TO THE NEUROSURGERY BRAIN TUMOR PROGRAM RESEARCH FUND (60358C) FOR DR. LINDA LIAU. | 202512539349100111 |
| 2024 | The UCLA Foundation Los Angeles, CA | B | $37,500 | paid | FOR THE UCLA BRAIN CANCER RESEARCH GIFT FUND (61893C) LED BY DR. CLOUGHESY. | 202512539349100111 |
| 2024 | Central Brain Tumor Registry of the United States Hinsdale, IL | U | $5,000 | paid | GENERAL SUPPORT | 202512539349100111 |
| 2024 | Brain Tumor Epidemiology Consortium Hinsdale, IL | U | $5,000 | paid | BRAIN TUMOR EPIDEMIOLOGY CONSORTIUM ON MAY 15-17, 2024. | 202512539349100111 |
| 2023 | University of Southern California Los Angeles, CA | C | $50,000 | paid | BRAIN CANCER RESEARCH | 202423199349105022 |
| 2023 | The UCLA Foundation Pasadena, CA | C | $26,345 | paid | Neurosurgery Brain Tumor Program Research Fund | 202423199349105022 |
| 2023 | The UCLA Foundation Pasadena, CA | C | $26,345 | paid | UCLA Brain Cancer Research Gift Fund | 202423199349105022 |
| 2023 | The UCLA Foundation Pasadena, CA | C | $7,000 | paid | Medical Student Grant | 202423199349105022 |
| 2023 | Central Brain Tumor Registry of the United States Hinsdale, IL | U | $5,000 | paid | General & Unrestricted | 202423199349105022 |
| 2023 | Duke University Durham, NC | B | $3,500 | paid | Medical Student Research Grant | 202423199349105022 |
| 2023 | Brain Tumor Epidemiology Consortium Hinsdale, IL | U | $2,000 | paid | Charitable Event | 202423199349105022 |
| 2023 | Ourbrainbank Inc Rocklin, CA | U | $1,000 | paid | General & Unrestricted | 202423199349105022 |
| 2022 | The UCLA Foundation Pasadena, CA | C | $150,000 | paid | to conduct preclinical studies of a novel brain-penetrant epidermal growth factor receptor (EGFR) inhibitor and evaluate a noninvasive predictive biomarker of response to the EGFR in malignant GBM, leading to a clinical trial. | 202333169349100213 |
| 2022 | City of Hope Duarte, CA | U | $50,000 | paid | Engineering inhibitors of the ERKS axis proteins for glioblastoma treatment | 202333169349100213 |
| 2022 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | Repurposing Migraine Treatments for DIPG - 4th year funding | 202333169349100213 |
| 2022 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | Epigenetic Regulation in Pediatric High-Grade Gliomas - 2nd Year Funding | 202333169349100213 |
| 2022 | Society for Neuroscience Los Angeles, CA | C | $50,000 | paid | Characterizing PTPRZ1 Mechanism in Cancer as a Therapeutic Target | 202333169349100213 |
| 2022 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | Repurposing Migraine Treatments for DIPG - 3rd year funding | 202333169349100213 |
| 2022 | Cornell University - Weill Cornell Medicine New York, NY | U | $50,000 | paid | for the research project, "Targeting CAFs to sensitize irradiated glioblastoma to PD-1 blockade" | 202333169349100213 |
| 2022 | Mayo Clinic Rochester, MN | U | $50,000 | paid | TARGETING THE MALIGNANT INTERACTION BETWEEN GLIOBLASTOMA AND THE SUBVENTRICULAR ZONE - 2nd year funding | 202333169349100213 |
| 2022 | American Brain Tumor Association Chicago, IL | B | $50,000 | paid | Funding of Discover Grant | 202333169349100213 |
| 2022 | Duke University Durham, NC | B | $50,000 | paid | Research project: Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of Telomeres in Pediatric High-Grade Gliomas - 2nd Year Funding | 202333169349100213 |
| 2022 | The Regents of Ucsf San Francisco, CA | U | $50,000 | paid | Developing Multimodal Deep Learning for Outcome Prediction in Glioblastoma Patients After Radiation Therapy | 202333169349100213 |
| 2022 | Johns Hopkins University Baltimore, MD | U | $50,000 | paid | Alpha-particle radiotherapy for glioblastoma | 202333169349100213 |
| 2022 | The UCLA Foundation Pasadena, CA | C | $46,500 | paid | UCLA Brain Cancer Research Gift Fund | 202333169349100213 |
| 2022 | The UCLA Foundation Pasadena, CA | C | $46,500 | paid | Neurosurgery Brain Tumor Program Research Fund | 202333169349100213 |
| 2022 | Central Brain Tumor Registry of the United States Hinsdale, IL | U | $5,000 | paid | General & Unrestricted | 202333169349100213 |
| 2022 | Brain Tumor Epidemiology Consortium Hinsdale, IL | U | $2,000 | paid | To support the 2022 BTEC meeting in Lyon, France; Childhood Brain Tumors: Origins, Epidemiology, and Classification | 202333169349100213 |
| 2020 | The UCLA Foundation Los Angeles, CA | B | $150,000 | paid | to advance research in preclinical studies of a novel brain-penetrant epidermal growth factor receptor (EGFR) inhibitor and evaluate a noninvasive predictive biomarker of response to the EGFR in GBM, leading to a clinical trial lead by Dr. Cloughsey | 202143199349110299 |
| 2020 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | Project FP00009152 - Repurposing Migraine Treatments for DIPG - 2nd year funding | 202143199349110299 |
| 2020 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $50,000 | paid | Epigenetic Regulation in Pediatric High-Grade GlioMAS | 202143199349110299 |
| 2020 | Beckman Research Institute of the City of Hope Duarte, CA | U | $50,000 | paid | To support the research project: Overcoming Resistance to CAR T Immunotherapy with CBP/-catenin Antagonists ICG-001 in Brain Tumors: The Road Ahead Towards Metabolic Enhancement of Cancer Immunotherapy. | 202143199349110299 |
| 2020 | Duke University Durham, NC | B | $50,000 | paid | Research project: Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of Telomeres in Pediatric High-Grade Gliomas | 202143199349110299 |
| 2020 | Saint Johns Hospital & Health Center Foundation Santa Monica, CA | U | $38,000 | paid | To support Dr. Kesari's Neuroscience Research Center at PNI | 202143199349110299 |
| 2020 | Central Brain Tumor Registry of the United States Hinsdale, IL | U | $2,000 | paid | General & Unrestricted | 202143199349110299 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202512539349100111 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202423199349105022 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202333169349100213 |
| 990PF | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202143199349110299 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/464485313.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.